Gyre Therapeutics
GYRE
GYRE
32 hedge funds and large institutions have $7.26M invested in Gyre Therapeutics in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 11 reducing their positions, and 4 closing their positions.
Holders
32
Holders Change
-3
Holders Change %
-8.57%
% of All Funds
0.85%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
1
Increased
2
Reduced
11
Closed
4
Calls
$25K
Puts
$13K
Net Calls
+$12K
Net Calls Change
-$34K
Top Buyers
| 1 |
1
T. Rowe Price Associates
Baltimore,
Maryland
|
$41K |
| 2 |
2
Morgan Stanley
New York
|
$17K |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$405K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
NFA
26
Nationwide Fund Advisors
Columbus,
Ohio
| $2K | – | – | – |
|
|
PAM
27
Panagora Asset Management
Boston,
Massachusetts
| $2K | – | – | – |
|
|
BA
28
BlackRock Advisors
Wilmington,
Delaware
| $1K | – | – | – |
|
29
Geode Capital Management
Boston,
Massachusetts
| $43 | – | – | – |
|
30
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
| – | -$46K | -131 | Closed |
|
|
CG
31
Cutler Group
San Francisco,
California
| – | -$13K | -39 | Closed |
|
|
TRCT
32
Tower Research Capital (TRC)
New York
| – | -$2K | -5 | Closed |
|